Frank Hsu
Directeur/Membre du Conseil chez Karin Grunebaum Cancer Research Foundation
Postes actifs de Frank Hsu
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| Karin Grunebaum Cancer Research Foundation | Directeur/Membre du Conseil | - | - |
Historique de carrière de Frank Hsu
Anciens postes connus de Frank Hsu
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| APEXIGEN, INC. | Directeur Technique/Scientifique/R&D | - | 23/08/2023 |
| Sales & Marketing | - | - | |
| IMMUNE DESIGN CORP | Corporate Officer/Principal | 01/10/2013 | 01/01/2018 |
Zyngenia, Inc.
 Zyngenia, Inc. Drugstore ChainsRetail Trade Zyngenia, Inc. developed new class of bio-therapeutics. The company was founded by Joseph L. Amprey III, Carlos F. Barbas III and Peter Alec Kiener in 2008 and headquartered in Gaithersburg, MD. | Directeur Technique/Scientifique/R&D | 01/06/2012 | 01/06/2013 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Directeur Technique/Scientifique/R&D | 01/01/2002 | 01/01/2012 |
Yale Cancer Center
 Yale Cancer Center Hospital/Nursing ManagementHealth Services Yale Cancer Center operates as a cancer center. It offers cancer immunology, cancer prevention and control, developmental therapeutics, genomics, genetics and epigenetics, radiobiology and radiotherapy, signal transduction, virus and other infection-associated cancers programs. The company was founded in 1974 and is headquartered in New Haven, CT. | Corporate Officer/Principal | 01/01/1996 | 01/01/2002 |
| Stanford University | Corporate Officer/Principal | 01/01/1996 | 01/01/1996 |
| ONCTERNAL THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 26/08/2019 | - |
Formation de Frank Hsu
| Stanford University | Undergraduate Degree |
| Harvard Medical School | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 10 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 4 |
| Corporate Officer/Principal | 3 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 3 |
| Retail Trade | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ONCTERNAL THERAPEUTICS, INC. | Health Technology |
| APEXIGEN, INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
Zyngenia, Inc.
Zyngenia, Inc. Drugstore ChainsRetail Trade Zyngenia, Inc. developed new class of bio-therapeutics. The company was founded by Joseph L. Amprey III, Carlos F. Barbas III and Peter Alec Kiener in 2008 and headquartered in Gaithersburg, MD. | Retail Trade |
Immune Design Corp.
 Immune Design Corp. Pharmaceuticals: MajorHealth Technology Immune Design Corp. is a clinical-stage immunotherapy company focused on cancer with in vivo approaches designed to enable the body's immune system to fight disease. It develops multiple product candidates from its discovery platforms, ZVex and GLAAS. The company was founded by Steven G. Reed and David Baltimore on February 20, 2008 and is headquartered in Kenilworth, NJ. | Health Technology |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Yale Cancer Center
Yale Cancer Center Hospital/Nursing ManagementHealth Services Yale Cancer Center operates as a cancer center. It offers cancer immunology, cancer prevention and control, developmental therapeutics, genomics, genetics and epigenetics, radiobiology and radiotherapy, signal transduction, virus and other infection-associated cancers programs. The company was founded in 1974 and is headquartered in New Haven, CT. | Health Services |
| Karin Grunebaum Cancer Research Foundation |
